Roche Prepares Faricimab For Filing After Phase III AMD Data

Non-Inferior To Eylea With Longer Dosing Intervals

 
• By Alexandra Shimmings
Eye in an high tech environment
• Source: Shutterstock

More from Clinical Trials

More from R&D